Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
J Med Virol ; 74(1): 117-26, 2004 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-15258977

RESUMO

Human papillomavirus type 16 (HPV-16) classes (E, AA, As, Af1, Af2) and their variants have different geographic distribution and different degrees of association with cervical lesions. This study was designed to examine HPV-16 variants among Italian women and their prevalence in case patients (affected by invasive cervical carcinoma or cervical intraepithelial neoplasia grade 2-3 and cervical intraepithelial neoplasia grade 1), versus control subjects with normal cervical epithelium (controls). A total of 90 HPV-16 positive cervical samples from women of Italian Caucasian descent have been tested, including 36 invasive cervical carcinomas, 21 with cervical intraepithelial neoplasias grade 2-3, 17 with cervical intraepithelial neoplasia grade 1 and 16 controls. HPV-16 was detected with an E6/E7 gene-specific polymerase chain reaction, and variant HPV-16 classes and subclasses were identified by direct nucleotide sequencing of the region coding for the E6 and the E7 oncoproteins, the MY09/11-amplified highly conserved L1 region, and the long control region (LCR). Among the 90 HPV-16 samples, nine viral variants have been identified belonging to the European (Ep-T350 and E-G350) and non-European (AA and Af-1) branches. The E-G350 is the prevalent variant in all analyzed different disease stages being present in 55.5% of ICC, 52.4% of cervical intraepithelial neoplasias 2-3, 47.1% of cervical intraepithelial neoplasia grade 1, and 50.0% of control samples. The non-European variants AA and Af1, rarely detected in control samples, represent 33.3% of all HPV-16 infections in invasive cervical carcinoma (with a peak of 19.4% and 13.9%, respectively), showing a statistically significant increase in frequency in more advanced lesions (chi(2) trend = 7.2; P < 0.05). The prevalence of HPV-16 Ep-T350, however, is higher in controls (43.7%) and in of cervical intraepithelial neoplasia grade 1 (41.2%) than in cervical intraepithelial neoplasia grade 2-3 (28.6%) and in invasive cervical carcinoma (11.1%) cases strongly suggesting lack of progression for pre-neoplastic lesions associated with such variant. The increased frequency of non-European variants in invasive lesions suggests that they are more oncogenic than European variants. This could have implications for future diagnostic and therapeutic strategies.


Assuntos
Variação Genética , Papillomaviridae/genética , Infecções por Papillomavirus/virologia , Displasia do Colo do Útero/virologia , Neoplasias do Colo do Útero/virologia , Adulto , Idoso , Proteínas do Capsídeo/genética , Estudos de Casos e Controles , Progressão da Doença , Feminino , Genes Virais , Genótipo , Humanos , Itália/epidemiologia , Pessoa de Meia-Idade , Epidemiologia Molecular , Proteínas Oncogênicas Virais/genética , Papillomaviridae/classificação , Papillomaviridae/isolamento & purificação , Proteínas E7 de Papillomavirus , Infecções por Papillomavirus/epidemiologia , Filogenia , Reação em Cadeia da Polimerase , Proteínas Repressoras/genética , Análise de Sequência de DNA , Neoplasias do Colo do Útero/epidemiologia , Displasia do Colo do Útero/epidemiologia
2.
J Gen Virol ; 81(Pt 12): 2969-2982, 2000 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-11086128

RESUMO

Human papillomavirus type 16 (HPV-16) is the predominant HPV isolate found in malignancies of male and female lower genital tracts. However, only a small percentage of individuals infected with high-risk HPVs develop a genital neoplasia, suggesting that additional events at both the cellular and the virus level are necessary for the progression to cancer, including genetic mutations/rearrangements of viral sequences involved in the oncogenic process. In this study, the genetic stability of the long control region (LCR) (nt 7289-114), which regulates expression levels of oncoproteins E6 and E7, was analysed in HPV-16 isolates from penile carcinoma (PC) biopsies of patients recruited from Uganda, one of the countries with the highest incidence of genital cancers in both men and women. Nucleotide changes within the LCR region typical of the African-1 (Af-1) lineage were observed in all HPV-16 isolates. Two out of five samples showed further rearrangements of the enhancer region. The functional activity of LCR with Af-1 mutations and/or rearrangements was evaluated by cloning each LCR into CAT expression vectors, followed by transfection in several epithelial and non-epithelial cell lines. CAT expression levels driven by a rearranged LCR were significantly higher than those driven by Af-1 or European prototype LCRs. Furthermore, in the NIH3T3 focus formation assay, the transforming activity of E6 and E7 genes, driven by a mutated or rearranged LCR, was 1.4- to 3.0-fold higher, respectively. These results indicate that rearrangements within the LCR of HPV-16 isolated from African PCs are frequently found (2 out of 5, 40%). It is also shown that increased HPV LCR activity is associated with an increased E6/E7-mediated in vitro transforming activity, suggesting that natural variants can play a major role in the pathogenesis of genital carcinomas.


Assuntos
Regulação Viral da Expressão Gênica , Variação Genética/genética , Papillomaviridae/genética , Papillomaviridae/isolamento & purificação , Neoplasias Penianas/virologia , Regiões Promotoras Genéticas/genética , Proteínas Repressoras , Células 3T3 , Animais , Sequência de Bases , Transformação Celular Neoplásica/genética , DNA Viral/genética , Elementos Facilitadores Genéticos/genética , Células Epiteliais/virologia , Genes Reporter/genética , Genes Virais/genética , Humanos , Incidência , Masculino , Camundongos , Dados de Sequência Molecular , Mutação/genética , Proteínas Oncogênicas Virais/genética , Papillomaviridae/patogenicidade , Proteínas E7 de Papillomavirus , Neoplasias Penianas/epidemiologia , Alinhamento de Sequência , Ativação Transcricional , Transfecção , Células Tumorais Cultivadas , Ensaio Tumoral de Célula-Tronco , Uganda/epidemiologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA